There has been a great deal of interest and comment recently about the use of mesh as part of the surgical treatment of vaginal prolapse and urinary incontinence. There is currently a Senate Inquiry into the Number of women in Australia who have had transvaginal mesh implants and related matters which is due to report its findings by 14 February 2018.
On 30 November 2017, the Therapeutic Goods Administration removed a number of mesh products whose sole use is the treatment of pelvic organ prolapse via transvaginal implantation from the Australian Register of Therapeutic Goods.
ACT Health is directly contacting all women that have been identified as having undergone surgery or treatment of this type at Canberra Hospital and Health Services within the past 10 years to notify them of the issue and the options available to them if they are concerned.
If you have undergone surgery or treatment of this type and have any concerns or questions, please contact your GP or gynaecologist directly, or call the dedicated Mesh telephone service at ACT Health on 02 6174 7474 or email email@example.com for information and support.